{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:40:20Z","timestamp":1775198420389,"version":"3.50.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-024-00716-3","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T09:59:17Z","timestamp":1735898357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3970-7690","authenticated-orcid":false,"given":"Yong Dam","family":"Jeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1185-3987","authenticated-orcid":false,"given":"Keisuke","family":"Ejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1474-5348","authenticated-orcid":false,"given":"Shoya","family":"Iwanami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8545-5212","authenticated-orcid":false,"given":"Robin N.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il Hyo","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Iwami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Ajelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"716_CR1","doi-asserted-by":"publisher","first-page":"e0242128","DOI":"10.1371\/journal.pone.0242128","volume":"15","author":"MA Billah","year":"2020","unstructured":"Billah, M. A., Miah, M. M. & Khan, M. N. Reproductive number of coronavirus: a systematic review and meta-analysis based on global level evidence. PLoS ONE 15, e0242128 (2020).","journal-title":"PLoS ONE"},{"key":"716_CR2","doi-asserted-by":"crossref","unstructured":"Zhen-Dong T. et al. Potential presymptomatic transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerging Infectious Dis. J. 26, 1052 (2020).","DOI":"10.3201\/eid2605.200198"},{"key":"716_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.15585\/mmwr.mm6913e1","volume":"69","author":"A Kimball","year":"2020","unstructured":"Kimball, A. et al. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility\u2014King County, Washington, March 2020. MMWR Morb. Mortal. Wkly. Rep. 69, 377\u2013381 (2020).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"716_CR4","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1056\/NEJMoa2008457","volume":"382","author":"MM Arons","year":"2020","unstructured":"Arons, M. M. et al. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N. Engl. J. Med. 382, 2081\u20132090 (2020).","journal-title":"N. Engl. J. Med."},{"key":"716_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21710-6","volume":"12","author":"S Hu","year":"2021","unstructured":"Hu, S. et al. Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. Nat. Commun. 12, 1533 (2021).","journal-title":"Nat. Commun."},{"key":"716_CR6","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1377\/hlthaff.2021.00619","volume":"40","author":"S Gupta","year":"2021","unstructured":"Gupta, S. et al. Vaccinations against COVID-19 may have averted up to 140,000 deaths in the United States. Health Aff. 40, 1465\u20131472 (2021).","journal-title":"Health Aff."},{"key":"716_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMc2119432","volume":"386","author":"LJ Abu-Raddad","year":"2022","unstructured":"Abu-Raddad, L. J., Chemaitelly, H. & Bertollini, R. Waning mRNA-1273 vaccine effectiveness against SARS-CoV-2 Infection in Qatar. N. Engl. J. Med. 386, 1091\u20131093 (2022).","journal-title":"N. Engl. J. Med."},{"key":"716_CR8","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews, N. et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N. Engl. J. Med. 386, 1532\u20131546 (2022).","journal-title":"N. Engl. J. Med."},{"key":"716_CR9","doi-asserted-by":"publisher","first-page":"e069052","DOI":"10.1136\/bmj-2021-069052","volume":"376","author":"M Fabiani","year":"2022","unstructured":"Fabiani, M. et al. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study. BMJ 376, e069052 (2022).","journal-title":"BMJ"},{"key":"716_CR10","doi-asserted-by":"crossref","unstructured":"Menni, C. et al. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study. Lancet Infectious Dis. 22, 1002\u20131010 (2022).","DOI":"10.1016\/S1473-3099(22)00146-3"},{"key":"716_CR11","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","volume":"399","author":"DR Feikin","year":"2022","unstructured":"Feikin, D. R. et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet 399, 924\u2013944 (2022).","journal-title":"Lancet"},{"key":"716_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41591-023-02212-y","volume":"29","author":"K Leung","year":"2023","unstructured":"Leung, K., Lau, E. H. Y., Wong, C. K. H., Leung, G. M. & Wu, J. T. Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November-December 2022. Nat. Med. 29, 579\u2013582 (2023).","journal-title":"Nat. Med."},{"key":"716_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38201-5","volume":"14","author":"R Xie","year":"2023","unstructured":"Xie, R. et al. Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong. Nat. Commun. 14, 2422 (2023).","journal-title":"Nat. Commun."},{"key":"716_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41562-022-01506-4","volume":"7","author":"BA Betthauser","year":"2023","unstructured":"Betthauser, B. A., Bach-Mortensen, A. M. & Engzell, P. A systematic review and meta-analysis of the evidence on learning during the COVID-19 pandemic. Nat. Hum. Behav. 7, 375\u2013385 (2023).","journal-title":"Nat. Hum. Behav."},{"key":"716_CR15","unstructured":"Bird, K. A., Castleman, B. L. & Lohner, G. Negative impacts from the shift to online learning during the COVID-19 crisis: evidence from a statewide community college system. EdWorkingPaperscom (2020)."},{"key":"716_CR16","doi-asserted-by":"publisher","first-page":"e20185","DOI":"10.2196\/20185","volume":"22","author":"JF Huckins","year":"2020","unstructured":"Huckins, J. F. et al. Mental health and behavior of college students during the early phases of the COVID-19 pandemic: longitudinal smartphone and ecological momentary assessment study. J. Med. Internet Res. 22, e20185 (2020).","journal-title":"J. Med. Internet Res."},{"key":"716_CR17","doi-asserted-by":"crossref","unstructured":"Li, H. Y., Cao, H., Leung, D. Y. P.& Mak, Y. W. The psychological impacts of a COVID-19 outbreak on college students in China: a longitudinal study. Int. J. Environ. Res. Public Health 17, 3933 (2020).","DOI":"10.3390\/ijerph17113933"},{"key":"716_CR18","doi-asserted-by":"crossref","unstructured":"Wang, C. et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int. J. Environ. Res. Public Health 17, 1729 (2020).","DOI":"10.3390\/ijerph17051729"},{"key":"716_CR19","first-page":"e7541","volume":"12","author":"P Sahu","year":"2020","unstructured":"Sahu, P. Closure of universities due to coronavirus disease 2019 (COVID-19): impact on education and mental health of students and academic staff. Cureus 12, e7541 (2020).","journal-title":"Cureus"},{"key":"716_CR20","doi-asserted-by":"publisher","first-page":"9804","DOI":"10.3390\/su12239804","volume":"12","author":"F Toscano","year":"2020","unstructured":"Toscano, F. & Zappal\u00e0, S. Social isolation and stress as predictors of productivity perception and remote work satisfaction during the COVID-19 pandemic: the role of concern about the virus in a moderated double mediation. Sustainability 12, 9804 (2020).","journal-title":"Sustainability"},{"key":"716_CR21","doi-asserted-by":"crossref","unstructured":"Baudot, L. & Kelly, K. A survey of perceptions of remote work and work productivity in the United States during the COVID-19 shutdown. Available at SSRN 3646406 (2020).","DOI":"10.2139\/ssrn.3646406"},{"key":"716_CR22","doi-asserted-by":"crossref","unstructured":"Bartik, A. W., Cullen, Z. B., Glaeser, E. L., Luca, M. & Stanton, C. T. What Jobs are Being Done at Home During the Covid-19 Crisis? Evidence from Firm-Level Surveys. National Bureau of Economic Research Working Paper Series. No. 27422 (2020).","DOI":"10.3386\/w27422"},{"key":"716_CR23","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1097\/JOM.0000000000002236","volume":"63","author":"T Galanti","year":"2021","unstructured":"Galanti, T., Guidetti, G., Mazzei, E., Zappal\u00e0, S. & Toscano, F. Work from home during the COVID-19 outbreak: the impact on employees\u2019 remote work productivity, engagement, and stress. J. Occup. Environ. Med. 63, e426\u2013e432 (2021).","journal-title":"J. Occup. Environ. Med."},{"key":"716_CR24","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.abh2939","volume":"372","author":"J Lessler","year":"2021","unstructured":"Lessler, J. et al. Household COVID-19 risk and in-person schooling. Science 372, 1092\u20131097 (2021).","journal-title":"Science"},{"key":"716_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28731-9","volume":"13","author":"T Leng","year":"2022","unstructured":"Leng, T. et al. Quantifying pupil-to-pupil SARS-CoV-2 transmission and the impact of lateral flow testing in English secondary schools. Nat. Commun. 13, 1106 (2022).","journal-title":"Nat. Commun."},{"key":"716_CR26","doi-asserted-by":"publisher","first-page":"e1010158","DOI":"10.1371\/journal.pcbi.1010158","volume":"18","author":"T Leng","year":"2022","unstructured":"Leng, T. et al. Assessing the impact of lateral flow testing strategies on within-school SARS-CoV-2 transmission and absences: a modelling study. PLoS Comput. Biol. 18, e1010158 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"716_CR27","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1080\/22221751.2022.2128435","volume":"11","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022. Emerg. Microbes Infect. 11, 2800\u20132807 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"716_CR28","doi-asserted-by":"publisher","first-page":"e211085","DOI":"10.1001\/jamanetworkopen.2021.1085","volume":"4","author":"P Poletti","year":"2021","unstructured":"Poletti, P. et al. Association of age with likelihood of developing symptoms and critical disease among close contacts exposed to patients with confirmed SARS-CoV-2 infection in Italy. JAMA Netw. Open. 4, e211085 (2021).","journal-title":"JAMA Netw. Open."},{"key":"716_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S1473-3099(22)00069-X","volume":"22","author":"C Cohen","year":"2022","unstructured":"Cohen, C. et al. SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21. Lancet Infect. Dis. 22, 821\u2013834 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"716_CR30","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","volume":"26","author":"X He","year":"2020","unstructured":"He, X. et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 26, 672\u2013675 (2020).","journal-title":"Nat. Med."},{"key":"716_CR31","doi-asserted-by":"publisher","first-page":"20201014","DOI":"10.1098\/rsif.2020.1014","volume":"18","author":"FA Lovell-Read","year":"2021","unstructured":"Lovell-Read, F. A., Funk, S., Obolski, U., Donnelly, C. A. & Thompson, R. N. Interventions targeting non-symptomatic cases can be important to prevent local outbreaks: SARS-CoV-2 as a case study. J. R. Soc. Interface 18, 20201014 (2021).","journal-title":"J. R. Soc. Interface"},{"key":"716_CR32","doi-asserted-by":"publisher","first-page":"eabd5393","DOI":"10.1126\/sciadv.abd5393","volume":"7","author":"DB Larremore","year":"2021","unstructured":"Larremore, D. B. et al. Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci. Adv. 7, eabd5393 (2021).","journal-title":"Sci. Adv."},{"key":"716_CR33","first-page":"100592","volume":"29","author":"Z Chen","year":"2022","unstructured":"Chen, Z. et al. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai China: a descriptive study. Lancet Reg. Health West Pac. 29, 100592 (2022).","journal-title":"Lancet Reg. Health West Pac."},{"key":"716_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27939-5","volume":"13","author":"QH Liu","year":"2022","unstructured":"Liu, Q. H. et al. Model-based evaluation of alternative reactive class closure strategies against COVID-19. Nat. Commun. 13, 322 (2022).","journal-title":"Nat. Commun."},{"key":"716_CR35","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","volume":"361","author":"JSM Peiris","year":"2003","unstructured":"Peiris, J. S. M. et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361, 1767\u20131772 (2003).","journal-title":"Lancet"},{"key":"716_CR36","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJMc2001737","volume":"382","author":"L Zou","year":"2020","unstructured":"Zou, L. et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 382, 1177\u20131179 (2020).","journal-title":"N. Engl. J. Med."},{"key":"716_CR37","doi-asserted-by":"publisher","first-page":"e69340","DOI":"10.7554\/eLife.69340","volume":"10","author":"YD Jeong","year":"2021","unstructured":"Jeong, Y. D. et al. Revisiting the guidelines for ending isolation for COVID-19 patients. eLife 10, e69340 (2021).","journal-title":"eLife"},{"key":"716_CR38","doi-asserted-by":"publisher","first-page":"100454","DOI":"10.1016\/j.epidem.2021.100454","volume":"35","author":"K Ejima","year":"2021","unstructured":"Ejima, K. et al. Estimation of the incubation period of COVID-19 using viral load data. Epidemics 35, 100454 (2021).","journal-title":"Epidemics"},{"key":"716_CR39","doi-asserted-by":"publisher","first-page":"20200947","DOI":"10.1098\/rsif.2020.0947","volume":"18","author":"K Ejima","year":"2021","unstructured":"Ejima, K. et al. Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model. J. R. Soc. Interface 18, 20200947 (2021).","journal-title":"J. R. Soc. Interface"},{"key":"716_CR40","doi-asserted-by":"publisher","first-page":"e3001128","DOI":"10.1371\/journal.pbio.3001128","volume":"19","author":"KS Kim","year":"2021","unstructured":"Kim, K. S. et al. A quantitative model used to compare within-host SARS-CoV\u22122, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2. PLoS Biol. 19, e3001128 (2021).","journal-title":"PLoS Biol."},{"key":"716_CR41","doi-asserted-by":"publisher","first-page":"e1003660","DOI":"10.1371\/journal.pmed.1003660","volume":"18","author":"S Iwanami","year":"2021","unstructured":"Iwanami, S. et al. Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: a modeling study. PLoS Med. 18, e1003660 (2021).","journal-title":"PLoS Med."},{"key":"716_CR42","doi-asserted-by":"publisher","first-page":"eabc7112","DOI":"10.1126\/sciadv.abc7112","volume":"6","author":"A Goyal","year":"2020","unstructured":"Goyal, A., Cardozo-Ojeda, E. F. & Schiffer, J. T. Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response. Sci. Adv. 6, eabc7112 (2020).","journal-title":"Sci. Adv."},{"key":"716_CR43","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/psp4.12543","volume":"9","author":"A Gon\u00e7alves","year":"2020","unstructured":"Gon\u00e7alves, A. et al. Timing of antiviral treatment initiation is critical to reduce SARS\u2010CoV\u20102 viral load. CPT Pharmacomet. Syst. Pharmacol. 9, 509\u2013514 (2020).","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"716_CR44","doi-asserted-by":"publisher","first-page":"8847","DOI":"10.1073\/pnas.1704011114","volume":"114","author":"K Best","year":"2017","unstructured":"Best, K. et al. Zika plasma viral dynamics in nonhuman primates provides insights into early infection and antiviral strategies. Proc. Natl Acad. Sci. Usa. 114, 8847\u20138852 (2017).","journal-title":"Proc. Natl Acad. Sci. Usa."},{"key":"716_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32663-9","volume":"13","author":"YD Jeong","year":"2022","unstructured":"Jeong, Y. D. et al. Designing isolation guidelines for COVID-19 patients with rapid antigen tests. Nat. Commun. 13, 4910 (2022).","journal-title":"Nat. Commun."},{"key":"716_CR46","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469 (2020).","journal-title":"Nature"},{"key":"716_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20568-4","volume":"12","author":"JJ van Kampen","year":"2021","unstructured":"van Kampen, J. J. et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat. Commun. 12, 1\u20136 (2021).","journal-title":"Nat. Commun."},{"key":"716_CR48","doi-asserted-by":"publisher","unstructured":"Marc, A. et al. Quantifying the relationship between SARS-CoV-2 viral load and infectiousness. medRxiv https:\/\/doi.org\/10.1101\/2021.05.07.21256341 (2021).","DOI":"10.1101\/2021.05.07.21256341"},{"key":"716_CR49","doi-asserted-by":"publisher","first-page":"e63537","DOI":"10.7554\/eLife.63537","volume":"10","author":"A Goyal","year":"2021","unstructured":"Goyal, A., Reeves, D. B., Cardozo-Ojeda, E. F., Schiffer, J. T. & Mayer, B. T. Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events. Elife 10, e63537 (2021).","journal-title":"Elife"},{"key":"716_CR50","unstructured":"Centers for Disease Control and Prevention. COVID Data Tracker 2021. Available from https:\/\/covid.cdc.gov\/covid-data-tracker\/."},{"key":"716_CR51","doi-asserted-by":"crossref","unstructured":"Liu, Y., Gayle, A. A., Wilder-Smith, A. & Rocklov, J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J. Travel Med. 27, taaa021 (2020).","DOI":"10.1093\/jtm\/taaa021"},{"key":"716_CR52","doi-asserted-by":"crossref","unstructured":"Park, M., Cook, A. R., Lim, J. T., Sun, Y. & Dickens, B. L. A systematic review of COVID-19 epidemiology based on current evidence. J. Clin. Med. 9, 967 (2020).","DOI":"10.3390\/jcm9040967"},{"key":"716_CR53","doi-asserted-by":"crossref","unstructured":"Dehning, J. et al. Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions. Science 369, eabb9789 (2020).","DOI":"10.1126\/science.abb9789"},{"key":"716_CR54","doi-asserted-by":"publisher","first-page":"100311","DOI":"10.1016\/j.xcrm.2021.100311","volume":"2","author":"Y Yamaoka","year":"2021","unstructured":"Yamaoka, Y. et al. Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests. Cell Rep. Med. 2, 100311 (2021).","journal-title":"Cell Rep. Med."},{"key":"716_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26557-5","volume":"12","author":"KP Reddy","year":"2021","unstructured":"Reddy, K. P. et al. Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa. Nat. Commun. 12, 6238 (2021).","journal-title":"Nat. Commun."},{"key":"716_CR56","first-page":"e120","volume":"9","author":"KP Reddy","year":"2021","unstructured":"Reddy, K. P. et al. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. Lancet. Glob. Health 9, e120\u2013e129 (2021).","journal-title":"Glob. Health"},{"key":"716_CR57","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1016\/S2468-2667(21)00002-5","volume":"6","author":"Z Du","year":"2021","unstructured":"Du, Z., Pandey, A., Bai, Y., Fitzpatrick, M. C. & Chinazzi, M. et al. Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study. Lancet Public Health 6, e184\u2013e191 (2021).","journal-title":"Lancet Public Health"},{"key":"716_CR58","doi-asserted-by":"publisher","unstructured":"Jeong, Y. D. Safe return to schools and workplaces: a modelling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks 2023. Available from https:\/\/doi.org\/10.5281\/zenodo.8041485.","DOI":"10.5281\/zenodo.8041485"},{"key":"716_CR59","unstructured":"Centers for Disease Control and Prevention (CDC). Information for Pediatric Healthcare Providers 2024. Available from https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/pediatric-hcp.html."},{"key":"716_CR60","doi-asserted-by":"publisher","first-page":"1858 e1","DOI":"10.1016\/j.cmi.2021.08.001","volume":"27","author":"R Costa","year":"2021","unstructured":"Costa, R. et al. Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults. Clin. Microbiol. Infect. 27, 1858 e1\u2013e7 (2021).","journal-title":"Clin. Microbiol. Infect."},{"key":"716_CR61","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/S2666-5247(20)30172-5","volume":"2","author":"M Cevik","year":"2021","unstructured":"Cevik, M., Tate, M., Lloyd, O., Maraolo, A. E. & Schafers, J. Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe 2, e13\u2013e22 (2021).","journal-title":"Lancet Microbe"},{"key":"716_CR62","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1126\/science.abf9648","volume":"372","author":"M Pavelka","year":"2021","unstructured":"Pavelka, M. et al. The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia. Science 372, 635\u2013641 (2021).","journal-title":"Science"},{"key":"716_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-01982-x","volume":"19","author":"J Hellewell","year":"2021","unstructured":"Hellewell, J. et al. Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections. BMC Med. 19, 106 (2021).","journal-title":"BMC Med."},{"key":"716_CR64","doi-asserted-by":"publisher","first-page":"e2305451120","DOI":"10.1073\/pnas.2305451120","volume":"120","author":"WS Hart","year":"2023","unstructured":"Hart, W. S. et al. Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics: SARS-CoV-2 as a case study. Proc. Natl Acad. Sci. 120, e2305451120 (2023).","journal-title":"Proc. Natl Acad. Sci."},{"key":"716_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43043-2","volume":"14","author":"J Sunagawa","year":"2023","unstructured":"Sunagawa, J. et al. Isolation may select for earlier and higher peak viral load but shorter duration in SARS-CoV-2 evolution. Nat. Commun. 14, 7395 (2023).","journal-title":"Nat. Commun."},{"key":"716_CR66","doi-asserted-by":"publisher","first-page":"eabi5273","DOI":"10.1126\/science.abi5273","volume":"373","author":"TC Jones","year":"2021","unstructured":"Jones, T. C. et al. Estimating infectiousness throughout SARS-CoV-2 infection course. Science 373, eabi5273 (2021).","journal-title":"Science"},{"key":"716_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20568-4","volume":"12","author":"JJA van Kampen","year":"2021","unstructured":"van Kampen, J. J. A. et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat. Commun. 12, 267 (2021).","journal-title":"Nat. Commun."},{"key":"716_CR68","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41564-022-01105-z","volume":"7","author":"R Ke","year":"2022","unstructured":"Ke, R. et al. Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness. Nat. Microbiol. 7, 640\u2013652 (2022).","journal-title":"Nat. Microbiol."},{"key":"716_CR69","doi-asserted-by":"publisher","first-page":"2001483","DOI":"10.2807\/1560-7917.ES.2020.25.32.2001483","volume":"25","author":"A Singanayagam","year":"2020","unstructured":"Singanayagam, A. et al. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Eurosurveillance 25, 2001483 (2020).","journal-title":"Eurosurveillance"},{"key":"716_CR70","doi-asserted-by":"crossref","unstructured":"Marc, A. et al. Quantifying the relationship between SARS-CoV-2 viral load and infectiousness. Elife 10, e69302 (2021).","DOI":"10.7554\/eLife.69302"},{"key":"716_CR71","unstructured":"Dinnes, J. et al. Rapid, point\u2010of\u2010care antigen and molecular\u2010based tests for diagnosis of SARS\u2010CoV\u20102 infection. Cochrane Database Syst. Rev. 8, CD013705 (2021)."},{"key":"716_CR72","unstructured":"Li, B. et al. Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant. Nat. Commun. 13, 460 (2021)."},{"key":"716_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20990-2","volume":"12","author":"DM Feehan","year":"2021","unstructured":"Feehan, D. M. & Mahmud, A. S. Quantifying population contact patterns in the United States during the COVID-19 pandemic. Nat. Commun. 12, 893 (2021).","journal-title":"Nat. Commun."},{"key":"716_CR74","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1001\/jama.2021.0286","volume":"325","author":"MA Crane","year":"2021","unstructured":"Crane, M. A., Shermock, K. M., Omer, S. B. & Romley, J. A. Change in reported adherence to nonpharmaceutical interventions during the COVID-19 pandemic, April-November 2020. JAMA 325, 883\u2013885 (2021).","journal-title":"JAMA"},{"key":"716_CR75","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abb8001","volume":"368","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China. Science 368, 1481\u20131486 (2020).","journal-title":"Science"},{"key":"716_CR76","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.tpb.2020.12.003","volume":"137","author":"CL Shaw","year":"2021","unstructured":"Shaw, C. L. & Kennedy, D. A. What the reproductive number R(0) can and cannot tell us about COVID-19 dynamics. Theor. Popul Biol. 137, 2\u20139 (2021).","journal-title":"Theor. Popul Biol."},{"key":"716_CR77","doi-asserted-by":"publisher","first-page":"100712","DOI":"10.1016\/j.epidem.2023.100712","volume":"44","author":"C Molina Grane","year":"2023","unstructured":"Molina Grane, C. et al. SARS-CoV-2 transmission patterns in educational settings during the Alpha wave in Reggio-Emilia. Italy Epidemics. 44, 100712 (2023).","journal-title":"Italy Epidemics."},{"key":"716_CR78","doi-asserted-by":"publisher","first-page":"e13049","DOI":"10.1111\/irv.13049","volume":"17","author":"M Manica","year":"2023","unstructured":"Manica, M. et al. Estimating SARS-CoV-2 transmission in educational settings: A retrospective cohort study. Influenza Other Respir. Viruses. 17, e13049 (2023).","journal-title":"Influenza Other Respir. Viruses."},{"key":"716_CR79","doi-asserted-by":"publisher","unstructured":"Kissler, S. M. et al. Densely sampled viral trajectories for SARS-CoV-2 variants alpha (B. 1.1. 7) and epsilon (B. 1.429). medRxiv https:\/\/doi.org\/10.1101\/2021.02.16.21251535 (2021).","DOI":"10.1101\/2021.02.16.21251535"},{"key":"716_CR80","doi-asserted-by":"publisher","unstructured":"Kissler Stephen, M. et al. Sars-cov-2 viral dynamics in acute infections. medRxiv https:\/\/doi.org\/10.1101\/2020.10.21.20217042 (2020).","DOI":"10.1101\/2020.10.21.20217042"},{"key":"716_CR81","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ijid.2020.10.099","volume":"102","author":"S Jang","year":"2021","unstructured":"Jang, S., Rhee, J. Y., Wi, Y. M. & Jung, B. K. Viral kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period. Int J. Infect. Dis. 102, 561\u2013565 (2021).","journal-title":"Int J. Infect. Dis."},{"key":"716_CR82","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.3346\/jkms.2020.35.e142","volume":"35","author":"ES Kim","year":"2020","unstructured":"Kim, E. S. et al. Clinical course and outcomes of patients with severe acute respiratory syndrome coronavirus 2 infection: a preliminary report of the first 28 patients from the Korean Cohort Study on COVID-19. J. Korean Med Sci. 35, e142 (2020).","journal-title":"J. Korean Med Sci."},{"key":"716_CR83","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1001\/jama.2020.3204","volume":"323","author":"BE Young","year":"2020","unstructured":"Young, B. E. et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 323, 1488\u20131494 (2020).","journal-title":"JAMA"},{"key":"716_CR84","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1056\/NEJMc2013020","volume":"383","author":"A Sakurai","year":"2020","unstructured":"Sakurai, A. et al. Natural history of asymptomatic SARS-CoV-2 infection. N. Engl. J. Med. 383, 885\u2013886 (2020).","journal-title":"N. Engl. J. Med."},{"key":"716_CR85","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ijid.2020.04.083","volume":"95","author":"SE Kim","year":"2020","unstructured":"Kim, S. E. et al. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients. Int J. Infect. Dis. 95, 441\u2013443 (2020).","journal-title":"Int J. Infect. Dis."},{"key":"716_CR86","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1017\/S095026882100008X","volume":"149","author":"KQ Kam","year":"2021","unstructured":"Kam, K. Q. et al. SARS-CoV-2 viral RNA load dynamics in the nasopharynx of infected children. Epidemiol. Infect. 149, e18 (2021).","journal-title":"Epidemiol. Infect."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00716-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00716-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00716-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T11:09:40Z","timestamp":1735902580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00716-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["716"],"URL":"https:\/\/doi.org\/10.1038\/s43856-024-00716-3","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"13 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.A. has received research funding from Seqirus. The funding is not related to the current research. K.E. and S.Iwami received funding from Fujifilm Corporation, which produces and sells SARS-CoV-2 antigen rapid diagnostic tests. However, this competing interest did not influence the design, execution, or interpretation of the study. The authors declare that they have no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}